Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer.
A. Rink, J. Borg, A. Simeonov, Gerald O'Leary, J. Helou, C. Ménard, P. Chung, D. Jaffray, A. Berlin
2017.7.1Brachytherapy
Paper details
- Journal
- Brachytherapy
- Published
- 2017.7.1
- Citations
- 8
- References
- 19
- Fields
- Engineering, Medicine
tlooto Summary
Volumetric changes were observed during the time between planning MR and ptMR, resulting in reduction in coverage for both prostate and planning target volume, and treatment plans for both whole- and partial-gland therapies remained clinically acceptable.
Abstract
Abstract is not available.
Citation format
RINK, A., et al. Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer. Brachytherapy, 2017, 17 1(1): 59–67.